For decades, artificial intelligence advanced in careful, mostly linear steps. Researchers built models. Engineers improved performance. Organizations deployed systems to automate specific tasks. Each ...

Amber Implants, a Netherlands medtech developing next-generation implants for spinal injuries, named Vincent Gardès as CEO.

Information pervades the universe, yet means nothing. Meaning emerged when matter organized into systems that could ...

CloseMate today opened early access for the world's first Fully Autonomous CRM powered by AGI-grade logic, introducing a shift from Software as a Service to Service as Software, a paradigm where you ...

A newly revealed customs contract shows US Border Patrol has a £55,000 ($75,000) taxpayer-funded deal with Four Seasons Pet ...

A new movement of people seeking connection and purpose forget they’re talking to AI and project their vulnerabilities onto ...

Now imagine that sensation amplified a hundredfold, and you’ve got the Guardian Angel Thrift Store experience in Fuquay-Varina, North Carolina. This isn’t your run-of-the-mill secondhand shop where ...

Following a thrilling end to the 2025 season, where Lando Norris secured his first Formula 1 world title in a three-way showdown to the wire, it's time to build up to the new 2026 season. In what is a ...

"Data As Of" refers to the Closing Sale. Volume is updated throughout the after hours market. Note: Daily closing values are valid as of 5:15 p.m. ET. Duplicate values disseminated after 5:15 p.m. ET.

Marshall Hargrave is a stock analyst and writer with 10+ years of experience covering stocks and markets, as well as analyzing and valuing companies. Gordon Scott has been an active investor and ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...